Chairman Waxman Urges Strong Response to Report on FDA Resource Shortfalls

Chairman Waxman wrote to FDA Commissioner von Eschenbach, Secretary Leavitt, and OMB Director Nussle regarding the FDA Science Board’s Subcommittee on Science and Technology report that found that funding shortages at FDA have undermined science and endangered public health. Chairman Waxman urges these agencies to request adequate funding and resources for FDA.